Erratum: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors (Breast Cancer Research and Treatment (2009) 117 (183-191) DOI: 10.1007/s10549-008-0087-1);Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors

Breast Cancer Research and Treatment

Volumn 117, Issue 1, 2009, Pages 183-191

  Bane, Anita L ^a,b   Pinnaduwage, Dushanthi ^a   Colby, Sarah ^a   Bull, Shelley B ^a,c   O'Malley, Frances P ^a,b   Andrulis, Irene L ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA1; BRCA2; Expression profiling; Familial breast cancer

Indexed keywords

BRCA2 PROTEIN; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; JAGGED1; OSTEOPONTIN; STATHMIN; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL TYPE; FAMILIAL CANCER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; VALIDATION STUDY;

EID: 69049107970     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0563-2     Document Type: Erratum

References (51)

1. AL Bane JC Beck et al. 2007 BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays Am J Surg Pathol 31 121 128 10.1097/01.pas.0000213351. 49767.0f
2. SR Lakhani J Jacquemier et al. 1998 Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1138 1145 10.1093/jnci/90.15.1138
3. SR Lakhani JS Reis-Filho et al. 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 5175 5180 10.1158/1078-0432.CCR-04-2424
4. J Palacios E Honrado et al. 2005 Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers Breast Cancer Res Treat 90 5 14 10.1007/s10549-004-1536-0
5. T Sorlie R Tibshirani et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100
6. TO Nielsen FD Hsu et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 10.1158/1078-0432.CCR-04-0220
7. I Hedenfalk D Duggan et al. 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 539 548 10.1056/NEJM200102223440801
8. EM John JL Hopper et al. 2004 The breast cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Res 6 R375 R389 10.1186/bcr801
9. HJ Sutherland J Lacroix et al. 2001 The cooperative familial registry for breast cancer studies: design and first year recruitment rates in Ontario J Clin Epidemiol 54 93 98 10.1016/S0895-4356(00)00263-8
10. IL Andrulis H Anton-Culver et al. 2002 Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations Hum Mutat 20 65 73 10.1002/humu.10097
11. Tavassoli T, Devilee P (2003) Pathology & Genetics. Tumours of the breast and female genital organs. IARC Press, Lyon
12. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 10.1111/j.1365-2559. 1991.tb00229.x
13. CM Perou T Sorlie et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10.1038/35021093
14. Simon R, Korn E (2003) Design and analysis of DNA microarray investigations. Springer-Verlag, New York
15. YH Yang S Dudoit et al. 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucl Acids Res 30 e15 10.1093/nar/30.4.e15
16. Smyth GK (2005) Limma: linear models for microarray data. In: Bioinformatic and computional biology solutions using R and bioconductor. Springer, New York
17. M Reedijk S Odorcic et al. 2005 High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival Cancer Res 65 8530 8537 10.1158/0008-5472.CAN-05-1069
18. DC Allred JM Harvey et al. 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 155 168
19. VG Tusher R Tibshirani et al. 2001 Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 5116 5121 10.1073/pnas.091062498
20. SM Pinilla E Honrado et al. 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer Breast Cancer Res Treat 99 85 90 10.1007/s10549-006-9184-1
21. Reedijk M, Pinnaduwage D et al (2007) JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat, Nov 8 [Epub]
22. H Uyttendaele J Ho et al. 2001 Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium Proc Natl Acad Sci USA 98 5643 5648 10.1073/pnas.091584598
23. B Varnum-Finney LE Purton et al. 1998 The notch ligand, jagged-1, influences the development of primitive hematopoietic precursor cells Blood 91 4084 4091
24. L Dailey D Ambrosetti et al. 2005 Mechanisms underlying differential responses to FGF signaling Cytokine Growth Factor Rev 16 233 247 10.1016/j.cytogfr.2005.01.007
25. SW McLeskey IY Ding et al. 1994 MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands Cancer Res 54 523 530
26. L Zhang S Kharbanda et al. 1997 MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice Oncogene 15 2093 2108 10.1038/sj.onc.1201386
27. EH van Beers T van Welsem et al. 2005 Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations Cancer Res 65 822 827
28. A Bergamaschi YH Kim et al. 2006 Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer Genes Chromosomes Cancer 45 1033 1040 10.1002/gcc.20366
29. L De Moerlooze B Spencer-Dene et al. 2000 An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis Development 127 483 492
30. AA Mailleux B Spencer-Dene et al. 2002 Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo Development 129 53 60
31. GS Bansal HC Cox et al. 1997 Expression of keratinocyte growth factor and its receptor in human breast cancer Br J Cancer 75 1567 1574
32. RP Carstens JV Eaton et al. 1997 Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer Oncogene 15 3059 3065 10.1038/sj.onc.1201498
33. JM Otte F Schmitz et al. 2000 Expression of keratinocyte growth factor and its receptor in colorectal cancer Eur J Clin Invest 30 222 229 10.1046/j.1365-2362.2000.00617.x
34. AB Moffa SL Tannheimer et al. 2004 Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells Mol Cancer Res 2 643 652
35. VD Blanckaert M Hebbar et al. 1998 Basic fibroblast growth factor receptors and their prognostic value in human breast cancer Clin Cancer Res 4 2939 2947
36. F Penault-Llorca F Bertucci et al. 1995 Expression of FGF and FGF receptor genes in human breast cancer Int J Cancer 61 170 176 10.1002/ijc.2910610205
37. DF Easton KA Pooley et al. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093
38. DJ Hunter P Kraft et al. 2007 A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 39 870 874 10.1038/ng2075
39. PL Fitzgibbons DL Page et al. 2000 Prognostic factors in breast cancer. College of American pathologists consensus statement 1999 Arch Pathol Lab Med 124 966 978
40. AL Stratford G Habibi et al. 2007 Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer providing a potential target for therapy Breast Cancer Res 9 R61 10.1186/bcr1767
41. MJ van de Vijver YD He et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009 10.1056/NEJMoa021967
42. C Fan DS Oh et al. 2006 Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 560 569 10.1056/NEJMoa052933
43. G Brattsand 2000 Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors Br J Cancer 83 311 318 10.1054/bjoc.2000.1264
44. N Shijubo T Uede et al. 2000 Vascular endothelial growth factor and osteopontin in tumor biology Crit Rev Oncog 11 135 146
45. AB Tuck BE Elliott et al. 2000 Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (met) J Cell Biochem 78 465 475 10.1002/1097-4644(20000901)78:3<465::AID-JCB11>3.0.CO;2-C
46. AB Tuck C Hota et al. 2003 Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways Oncogene 22 1198 1205 10.1038/sj.onc.1206209
47. AL Allan R George et al. 2006 Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer Am J Pathol 169 233 246 10.2353/ajpath.2006.051152
48. HL Moses R Serra 1996 Regulation of differentiation by TGF-beta Curr Opin Genet Dev 6 581 586 10.1016/S0959-437X(96)80087-6
49. AB Roberts LM Wakefield 2003 The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci USA 100 8621 8623 10.1073/pnas. 1633291100
50. G Dontu KW Jackson et al. 2004 Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells Breast Cancer Res 6 R605 R615 10.1186/bcr920
51. M Shipitsin LL Campbell et al. 2007 Molecular definition of breast tumor heterogeneity Cancer Cell 11 259 273 10.1016/j.ccr.2007.01.013